Back to User profile » Professor Yunjin Jung
Papers published by Professor Yunjin Jung:
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model
Yang Y, Kim W, Kim D, Jeong S, Yoo JW, Jung Y
Drug Design, Development and Therapy 2019, 13:231-242
Published Date: 28 December 2018
Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis
Naeem M, Bae J, Oshi MA, Kim M, Moon HR, Lee BL, Im E, Jung Y, Yoo J
International Journal of Nanomedicine 2018, 13:1225-1240
Published Date: 28 February 2018
Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes
Kim W, Yang Y, Kim D, Jeong S, Yoo J, Yoon JH, Jung Y
Drug Design, Development and Therapy 2017, 11:419-429
Published Date: 14 February 2017
Increased therapeutic efficacy of a newly synthesized tyrosinase inhibitor by solid lipid nanoparticles in the topical treatment of hyperpigmentation
Al-Amin M, Cao J, Naeem M, Banna H, Kim M, Jung Y, Chung HY, Moon HR, Yoo J
Drug Design, Development and Therapy 2016, 10:3947-3957
Published Date: 2 December 2016
Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
Lee S, Lee Y, Kim W, Nam J, Jeong S, Yoo JW, Kim MS, Moon HR, Jung Y
Drug Design, Development and Therapy 2015, 9:4227-4237
Published Date: 7 August 2015
Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancement
Yum S, Jeong S, Lee S, Nam J, Kim W, Yoo JW, Kim MS, Lee BL, Jung Y
Drug Design, Development and Therapy 2015, 9:4247-4258
Published Date: 4 August 2015
Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process
Ha ES, Kim JS, Baek I, Yoo JW, Jung Y, Moon HR, Kim MS
Drug Design, Development and Therapy 2015, 9:4269-4277
Published Date: 4 August 2015
Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl)acrylonitriles
Yun HY, Kim DH, Son S, Ullah S, Kim SJ, Kim YJ, Yoo JW, Jung YJ, Chun P, Moon HR
Drug Design, Development and Therapy 2015, 9:4259-4268
Published Date: 4 August 2015
Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery
Lee Y, Kim J, Kim W, Nam J, Jeong S, Lee S, Yoo JW, Kim MS, Jung Y
Drug Design, Development and Therapy 2015, 9:4105-4113
Published Date: 30 July 2015
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy
Naeem M, Choi MJ, Cao J, Lee Y, Ikram M, Yoon S, Lee J, Moon HR, Kim MS, Jung YJ, Yoo JW
Drug Design, Development and Therapy 2015, 9:3789-3799
Published Date: 21 July 2015
Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles
Naeem M, Cao J, Choi M, Kim WS, Moon HR, Lee BL, Kim MS, Jung Y, Yoo JW
International Journal of Nanomedicine 2015, 10:4565-4580
Published Date: 16 July 2015
Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization
Ha ES, Baek I, Yoo JW, Jung Y, Kim MS
Drug Design, Development and Therapy 2015, 9:3257-3266
Published Date: 24 June 2015
Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride
Baek I, Ha ES, Yoo JW, Jung Y, Kim MS
Drug Design, Development and Therapy 2015, 9:3231-3238
Published Date: 23 June 2015
Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity
Nurhasni H, Cao JF, Choi MJ, Kim I, Lee BL, Jung YJ, Yoo JW
International Journal of Nanomedicine 2015, 10:3065-3080
Published Date: 22 April 2015